| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.36 | 4e-12 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.23 | 7e-11 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.26 | 1e-06 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0004 |